Related Experiment Video
Updated: Mar 30, 2026
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Beyond clear cell: Rare histologic and molecular variants of renal cell carcinoma
Ali Moradi1, Jadon Fann1, George Zhang1
1Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
Abstract:
Renal cell carcinoma (RCC) represents a complex and heterogeneous group of renal malignancies, encompassing the predominant clear cell RCC (ccRCC) as well as a broad spectrum of nonclear cell RCC (non-ccRCC) subtypes. Advances in histopathology and genomic profiling have significantly refined RCC classification, enabling integration of morphological, immunohistochemical, and molecular features to enhance diagnostic precision, prognostication, and individualized treatment planning. While the 2022 5th edition of the WHO Classification continues to prioritize histopathologic assessment, it introduces a novel category of molecularly defined renal carcinomas, classifying tumors based on specific genetic and molecular features and reflecting advances in tumor biology. Herein, non-ccRCC includes different subtypes of papillary, chromophobe, tubulocystic, oncocytoma, eosinophilic solid and cystic, and collecting duct carcinomas, as well as several molecularly defined entities. Rare histological subtypes and molecularly characterized tumors, including ALK-rearranged, FH-deficient, SDH-deficient, TFEB/TFE3-rearranged, ELOC-mutated, and SMARCB1-deficient RCCs, demonstrate distinct clinical behavior, variable aggressiveness, and specific therapeutic vulnerabilities, underscoring the importance of accurate molecular diagnosis. Non-ccRCC subtypes remain a clinical challenge due to their relative rarity, histological heterogeneity, and underrepresentation in clinical trials, often necessitating the extrapolation of treatment paradigms from ccRCC. Emerging targeted therapies and immunotherapeutic strategies show promise for these rare RCCs, emphasizing the need for subtype-specific clinical research. This review provides a comprehensive overview of the histological and molecular rare variants of RCC, highlights diagnostic innovations, and discusses the implications of these insights for precision medicine and future therapeutic development in kidney cancer.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
02:30Histone Variants at the Centromere
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:24Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
01:10Nephrons